Alcon: UBS still a buyer, cuts TP

(CercleFinance.com) - UBS reinstates its "buy" rating on Alcon shares, albeit with a reduced target price of 83.
8 Swiss francs (vs. 88 Swiss francs), with its new target price representing 28% upside potential for the ophthalmology company's stock.

"Concerns around margin targets that are deliverable and short-term/minor weakness in Contact Lenses has driven a 10% share price decline," the broker points out, seeing this correction as a buy opportunity.

Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.